The majority of gastrointestinal stromal tumors (GISTs) are driven by a constitutively activating mutation in the KIT or PDGFRA (platelet-derived growth factor receptor alpha) receptor tyrosine kinase. Here, KIT is linked to gastrointestinal stromal tumor.